A detailed history of Janus Henderson Group PLC transactions in Artivion, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 17,038 shares of AORT stock, worth $475,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,038
Previous 17,239 1.17%
Holding current value
$475,189
Previous $364,000 20.05%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$19.62 - $25.65 $3,943 - $5,155
-201 Reduced 1.17%
17,038 $437,000
Q4 2023

Feb 14, 2024

SELL
$12.33 - $18.83 $382 - $583
-31 Reduced 0.18%
17,239 $308,000
Q3 2023

Nov 14, 2023

BUY
$14.82 - $17.52 $14 - $17
1 Added 0.01%
17,270 $261,000
Q2 2023

Aug 14, 2023

SELL
$12.78 - $17.23 $204 - $275
-16 Reduced 0.09%
17,269 $296,000
Q1 2023

May 15, 2023

BUY
$11.74 - $14.12 $202,925 - $244,064
17,285 New
17,285 $226,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.12B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.